Pharma and Biotech
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | 133.66 | (166.00) | 23.00p | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 198.60 | (83.41) | (11.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 169.67 | (149.77) | (19.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 30.35 | 30.35 | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 103.00p |
Change Today | -2.70p |
% Change | -2.55 % |
52 Week High | 275.00p |
52 Week Low | 92.75p |
Volume | 373,934 |
Shares Issued | 862.59m |
Market Cap | £888.46m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:02 | 200 @ 103.00p |
14:59 | 1 @ 103.10p |
14:59 | 2 @ 103.50p |
14:59 | 957 @ 103.42p |
14:54 | 1,439 @ 103.38p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research